Notice: You are viewing a basic version of this page. Are you using a very old browser? If so, please consider upgrading


KITE

Medical treatments and procedures, such as medicines and caesarean sections, are increasingly used during pregnancy. However, for many of them, we do not know enough about how they may positively or negatively affect the long-term health and development of babies as they grow into children. This lack of evidence matters, as it can lead to pregnant women avoiding or not being offered treatments or procedures that may be beneficial, or to risks going unrecognised. Better information is needed to help women, families and healthcare professionals make informed decisions about care during pregnancy.

In the UK, a lot of information about a person's health and development is collected when they visit their GP, use hospital services and go to school. It has recently become easier to link this 'routinely collected' health and education information, and link mothers' information with their children's information. Combining these developments with the latest research methods to improve evidence quality and transparency provides an opportunity to advance our understanding of the longer-term effects of treatments and procedures in pregnancy. This research programme will use this opportunity to:

  1. Carry out studies to compare the longer-term health and development of children whose mothers did and did not have certain treatments or procedures during pregnancy as part of their care. This will be done for two of the most common treatments/procedures used in pregnancy: planned caesarean section and medication to treat asthma, a condition that affects the airways and makes it harder to breathe.
  2. Continue following children whose mothers took part in a clinical trial to compare their longer-term health and development. This will be done for a trial of iron tablets during pregnancy to prevent anaemia, a common condition in pregnancy where the body lacks enough healthy red blood cells. In the trial, some mothers were given iron tablets and others were given an inactive tablet that looked like an iron tablet. Comparing the health and development of their children will help us understand the longer-term effects of giving iron tablets during pregnancy to prevent anaemia.

Doing this research will help answer important questions identified by the public, healthcare professionals and researchers. While it focuses on some of the most common issues in pregnancy, it can also show how routinely collected health and education information can be used to help us better understand the effects of other treatments and procedures in pregnancy. Improving the evidence in this area will give pregnant women, healthcare professionals, policymakers and regulators the information they need to make more informed decisions about the use of treatments and procedures in pregnancy. Importantly, this research will also help improve outcomes for families.

This programme is funded by Wellcome (322327/Z/24/Z) and is being led by Dr Kate Fitzpatrick with collaborators from the University of Oxford, St George's University of London, Boston University, the University of Aberdeen, UCL, and Cardiff University.

Updated: Friday, 06 November 2026 14:32 (v2)